| Literature DB >> 26365751 |
Defeng Wang1,2,3,4, Fengping Zhu5,6, Ka Ming Fung1, Wei Zhu5, Yishan Luo1,3, Winnie Chiu Wing Chu1, Vincent Chung Tong Mok7,8, Jinsong Wu5, Lin Shi7,8, Anil T Ahuja1, Ying Mao5.
Abstract
Moyamoya disease leads to the formation of stenosis in the cerebrovasculature. A superficial temporal artery to middle cerebral artery (STA-MCA) bypass is an effective treatment for the disease, yet it is usually associated with postoperative cerebral hyperperfusion syndrome (CHS). This study aimed to evaluate cerebral hemodynamic changes immediately after surgery and assess whether a semiquantitative analysis of an intraoperative magnetic resonance perfusion-weighted image (PWI) is useful for predicting postoperative CHS. Fourteen patients who underwent the STA-MCA bypass surgery were included in this study. An atlas-based registration method was employed for studying hemodynamics in different cerebral regions. Pre- versus intraoperative and group-wise comparisons were conducted to evaluate the hemodynamic changes. A postoperative increase in relative cerebral blood flow (CBF) at the terminal MCA territory (P = 0.035) and drop in relative mean-time-transit at the central MCA territory (P = 0.012) were observed in all patients. However, a significant raise in the increasing ratio of relative-CBF at the terminal MCA territory was only found in CHS patients (P = 0.023). The cerebrovascular changes of the patients after revascularization treatment were confirmed. Intraoperative PWI might be helpful in predicting the change in relative-CBF at MCA terminal territory which might indicate a risk of CHS.Entities:
Mesh:
Year: 2015 PMID: 26365751 PMCID: PMC4568478 DOI: 10.1038/srep14140
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Screenshots shows the axial, sagittal and coronal views and of the brain template and atlas used in this study.
Summary of mean relative cerebral blood flow (relative-CBF).
| All Patients (n = 14) | CHS Group (n = 5) | Non-CHS Group (n = 9) | P-value (CHS vs non-CHS) | |
|---|---|---|---|---|
| - Pre | 0.93 | 0.90 | 0.95 | 0.590 |
| - Intra | 0.92 | 0.93 | 0.91 | 0.818 |
| - %increase | –0.2% | 5.0% | –3.2% | 0.162 |
| P-value (Pre vs Intra) | 0.338 | 0.210 | 0.110 | |
| - Pre | 0.85 | 0.77 | 0.90 | 0.567 |
| - IntraIntra | 1.01 | 0.99 | 1.03 | 0.862 |
| - %increase | 32.7% | 58.6% | 18.4% | 0.518 |
| P-value (Pre vs Intra) | 0.047 | 0.169 | 0.098 | |
| - Pre | 0.98 | 1.03 | 0.95 | 0.333 |
| - Intra | 1.03 | 1.17 | 0.95 | 0.016 |
| - %increase | 5.1% | 14.3% | 0.0% | 0.023 |
| P-value (Pre vs Intra) | 0.035 | 0.011 | 0.471 | |
| - Pre | 0.96 | 1.07 | 0.90 | 0.386 |
| - Intra | 0.98 | 1.10 | 0.91 | 0.357 |
| - %increase | 2.3% | 4.3% | 1.2% | 0.721 |
| P-value (Pre vs Intra) | 0.266 | 0.347 | 0.326 | |
| - Pre | 1.01 | 0.92 | 1.06 | 0.268 |
| - Intra | 0.99 | 0.92 | 1.02 | 0.303 |
| - %increase | −1.2% | 3.4% | −3.8% | 0.338 |
| P-value (Pre vs Intra) | 0.241 | 0.452 | 0.146 | |
*significant P-values after multiple comparison correction.
Summary of mean relative cerebral blood volume (relative-CBV).
| All Patients (n = 14) | CHS Group (n = 5) | Non-CHS Group (n = 9) | P-value (CHS vs non-CHS) | |
|---|---|---|---|---|
| - Pre | 0.97 | 0.98 | 0.97 | 0.893 |
| - Intra | 0.94 | 0.94 | 0.94 | 0.986 |
| - %increase | −2.3% | −3.3% | −1.8% | 0.863 |
| P-value (Pre vs Intra) | 0.240 | 0.296 | 0.336 | |
| - Pre | 0.88 | 0.88 | 0.88 | 0.998 |
| - Intra | 1.06 | 1.02 | 1.09 | 0.777 |
| - %increase | 33.2% | 41.7% | 28.5% | 0.802 |
| P-value (Pre vs Intra) | 0.152 | 0.293 | 0.206 | |
| - Pre | 1.04 | 1.12 | 0.99 | 0.503 |
| - Intra | 1.05 | 1.32 | 0.90 | 0.152 |
| - %increase | 0.7% | 17.7% | −8.8% | 0.083 |
| P-value (Pre vs Intra) | 0.436 | 0.085 | 0.127 | |
| - Pre | 0.99 | 1.09 | 0.93 | 0.417 |
| - Intra | 0.99 | 1.15 | 0.90 | 0.275 |
| - %increase | 1.5% | 8.1% | −2.2% | 0.460 |
| P-value (Pre vs Intra) | 0.493 | 0.308 | 0.318 | |
| - Pre | 0.97 | 0.84 | 1.04 | 0.010 |
| - Intra | 0.97 | 1.00 | 0.95 | 0.472 |
| - %increase | 1.4% | 19.8% | –8.9% | 0.001 |
| P-value (Pre vs Intra) | 0.484 | 0.005 | 0.015 | |
*significant P-values after multiple comparison correction.
Summary of mean relative mean transit time (relative-MTT).
| All Patients (n = 14) | CHS Group (n = 5) | Non-CHS Group (n = 9) | P-value (CHS vs non-CHS) | |
|---|---|---|---|---|
| - Pre | 1.09 | 1.19 | 1.04 | 0.534 |
| - Intra | 1.03 | 1.03 | 1.04 | 0.954 |
| - %increase | −2.2% | −8.2% | 1.1% | 0.347 |
| P-value (Pre vs Intra) | 0.190 | 0.190 | 0.479 | |
| - Pre | 1.04 | 1.24 | 0.93 | 0.088 |
| - Intra | 0.98 | 1.02 | 0.96 | 0.612 |
| - %increase | −3.9% | −14.7% | 2.1% | 0.226 |
| P-value (Pre vs Intra) | 0.202 | 0.103 | 0.366 | |
| - Pre | 1.03 | 1.06 | 1.01 | 0.703 |
| - Intra | 1.00 | 1.07 | 0.97 | 0.428 |
| - %increase | −2.0% | 2.1% | −4.3% | 0.520 |
| P-value (Pre vs Intra) | 0.244 | 0.476 | 0.104 | |
| - Pre | 1.07 | 1.05 | 1.08 | 0.563 |
| - Intra | 0.97 | 0.99 | 0.96 | 0.583 |
| - %increase | −8.9% | −4.8% | −11.1% | 0.340 |
| P-value (Pre vs Intra) | 0.012 | 0.107 | 0.030 | |
| - Pre | 1.00 | 1.05 | 0.97 | 0.690 |
| - Intra | 1.05 | 1.20 | 0.97 | 0.312 |
| - %increase | 9.1% | 24.5% | 0.6% | 0.332 |
| P-value (Pre vs Intra) | 0.112 | 0.115 | 0.459 | |
*significant P-values after multiple comparison correction.
Figure 2Graph shows mean ± SD of pre- and intraoperative relative-CBF values in terminal MCA territory of CHS and non-CHS patients.
Figure 3(A) Preoperative MRA showing bilateral occlusion of the proximal ICA and Moyamoya change of intracranial vessels. (B) Intraoperative MRA showing the patency of left STA-MCA bypass graft (arrow). (C) Preoperative PWI demonstrating diminished CBF of the left hemisphere. (D) Intraoperative PWI demonstrating CBF of the left hemisphere markedly increased, mainly at the terminal MCA territory (arrow). (E) Preoperative PWI demonstrating prolonged MTT of the left hemisphere, especially at the terminal MCA territory. (F) Intraoperative PWI indicating the prolonged MTT of the left hemisphere didn’t change obviously.